drugset / Trial / NCT00376285
Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether fenofibrate effects the toleration, safety, or efficacy biomarkers of CP-742,033, a drug being developed for the treatment of obesity.
Timeline
- Start
- 2006-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DIRLOTAPIDE | Small molecule | — | — |
| Subject | Fenofibrate | Small molecule | — | — |